<DOC>
	<DOCNO>NCT03058588</DOCNO>
	<brief_summary>The aim study look predispose mutation patient relative affect AML MDS familial history myeloid , less frequently , lymphoid malignancy . Taking advantage next generation sequencing ( NGS ) platform , screen know unknown mutation potentially associate disease do . The screening perform affected unaffected family member , order outline new pedigree either validate previous finding constitute novel discovery .</brief_summary>
	<brief_title>Next Generation Sequencing ( NGS ) Familial Acute Myeloid Leukemia Myelodisplastic Syndromes</brief_title>
	<detailed_description>Patients diagnosis AML MDS least one relative affect AL/MDS , secondly , lymphoproliferative disorder , enrol study , refer index case . The analysis perform retrospectively prospectively . A gene panel deep sequencing ( GPDS ) tumor DNA peripheral blood index case diagnosis perform order identify mutation number gene know associated myeloid malignancy , mainly : ASXL1 , BCOR , NRAS , TP53 , RUNX1 , CEBPA , FLT3 , EZH2 , IDH1 , IDH2 , NPM1 , DNMT3A , TET2 , CBL , KRAS , ETV6 , SF3B1 , SRSF2 , U2AF1 , ZRSR2 , GATA2 , TERT , TERC , SRP72 , ANKRD26 . In case none know mutation find GPDS , whole exome sequencing ( WES ) perform second step tumor cell index case . When one multiple somatic mutation find , Sanger Sequencing ( SS ) germline DNA epithelial buccal cell index case affect relative perform screen somatic leukemic mutation germline DNA . If index case affect relative share mutation germline , germline mutation check SS unaffected family member .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>Inclusion criterion : Any patient acute myeloid leukemia ( AML ) Myelodisplastic Syndrome ( MDS ) : 1. first seconddegree relative Acute leukemia MDS myeloid malignancy 2. first seconddegree relative Lymphoproliferative neoplasm 3. clinical feature resemble one familial MDS/AML predisposition syndrome : History thrombocytopenia and/or clinical bleeding propensity ( RUNX1 , ANKRD26 ETV6 germline mutation ) Abnormal nail skin pigmentation , oral leukoplakia , idiopathic pulmonary fibrosis , unexplained liver disease ( TERT TERC germline mutation ) Lymphedema , atypical infection , immune deficiency ( GATA2 germline mutation ) 1. diagnosis acute myeloid leukemia ( AML ) Myelodisplastic Syndrome ( MDS ) ; 2. acute myeloid leukemia ( AML ) Myelodisplastic Syndrome ( MDS ) without first seconddegree relative Acute leukemia MDS myeloid malignancy without first seconddegree relative Lymphoproliferative neoplasm clinical feature resemble one familial MDS/AML predisposition syndrome ; 3. unability sign inform consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>